METHODS AND PRODUCTS FOR GENETIC ENGINEERING

Materials and Methods for Treatment of Hemoglobinopathies

CORRECTION OF DUCHENNE MUSCULAR DYSTROPHY MUTATIONS WITH ALL-IN-ONE ADENO-ASSOCIATED VIRUS-DELIVERED SINGLE-CUT CRISPR

METHODS AND COMPOSITIONS FOR REDUCING NUCLEIC ACID VECTOR-INDUCED TOXICITY IN THE INNER EAR

MODULATION OF GENE EXPRESSION FOR DISEASE TREATMENT

SITE-SPECIFIC CLEAVAGE AND ELIMINATION OF DNA IN BACTERIAL SPECIES WITH SEGMENTED CHROMOSOMES

NOVEL OMNI-50 CRISPR NUCLEASE

ZIP-IN TECHNOLOGY FOR ANTIVIRAL THERAPEUTIC NANOFORMULATIONS

ELECTROPHYSIOLOGICAL MODIFICATION TO SUPPRESS ARRHYTHMIAS

HYPOIMMUNOGENIC CELLS COMPRISING ENGINEERED HLA-E OR HLA-G

COMPOSITIONS AND METHODS FOR SELECTIVE ELIMINATION AND REPLACEMENT OF HEMATOPOIETIC STEM CELLS

SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING

CD94 ENGINEERED CELL AND COMPOSITION THEREOF

RECOMBINANT GENOME, AND NON-HUMAN MAMMALIAN CELL AND PRODUCTION METHOD THEREFOR AND USE THEREOF

BIRDS FOR PRODUCING FEMALE HATCHLING AND METHODS OF PRODUCING SAME

A MULTIPLEX CRISPR BASED ASSAY FOR THE SIMULTANEOUS DETECTION OF CHLAMYDIA TRACHOMATIS AND NEISSERIA GONORRHOEAE

MULTIPLEXED UNBIASED NUCLEIC ACID AMPLIFICATION METHOD

COMPOSITIONS OF MATTER FOR DETECTION ASSAYS

ENGINEERED EXTRACELLULAR VESICLES

NEGATIVE-STRAND RNA VIRAL VECTOR AND PLANT GENOME EDITING METHOD WITHOUT TRANSFORMATION

Targeted Destruction of Viral RNA by CRISPR-Cas13

Signal boost cascade assay

METHOD OF TREATING BREAST CANCER IN A SUBJECT BY INHIBITING NIP7 AND A PHARMACEUTICAL COMPOSITION COMPRISING A NIP7 INHIBITOR

PRIME EDITING-BASED GENE EDITING COMPOSITION WITH ENHANCED EDITING EFFICIENCY AND USE THEREOF

GUIDE RNAS WITH CHEMICAL MODIFICATION FOR PRIME EDITING

CLASS II, TYPE V CRISPR SYSTEMS

TRANSCRIPTIONAL CONTROL IN PROKARYOTIC CELLS USING DNA-BINDING REPRESSORS

NUCLEOSIDE TRIPHOSPHATE TRANSPORTER AND USES THEREOF

METHODS AND COMPOSITIONS FOR EXPRESSION OF EDITING PROTEINS

GENOMIC EDITING OF COMPLEMENT

ENGINEERED T CELLS CONDITIONALLY EXPRESSING A RECOMBINANT RECEPTOR, RELATED POLYNUCLEOTIDES AND METHODS

SYSTEMS AND METHODS FOR REGULATING ABERRANT GENE EXPRESSIONS

Engineered Macrophages for Cancer Immunotherapy

COMPRESSIVE MOLECULAR PROBES FOR GENOMIC EDITING AND TRACKING

RARE NUCLEIC ACID DETECTION

SINGLE-BUFFER COMPOSITIONS FOR NUCLEIC ACID DETECTION

COMPOSITIONS AND METHODS FOR PHOSPHORAMIDITE-FREE ENZYMATIC SYNTHESIS OF NUCLEIC ACIDS

SYSTEMS, METHODS, AND COMPONENTS FOR RNA-GUIDED EFFECTOR RECRUITMENT

SMALL CAS PROTEINS AND USES THEREOF

PLANT VIRUS MOVEMENT PROTEINS AND METHODS OF USING SAME

INHIBITORY NUCLEIC ACIDS FOR FACTOR H FAMILY PROTEINS

METHODS, SYSTEMS, AND APPARATUS FOR IDENTIFYING TARGET SEQUENCES FOR CAS ENZYMES OR CRISPR-CAS SYSTEMS FOR TARGET SEQUENCES AND CONVEYING RESULTS THEREOF

Systems and Methods for Modulating CRISPR Activity

NUCLEIC ACID BINDING PROTEIN FORMULATIONS AND USES THEREOF

MULTIPLEX CRISPR/Cas9-MEDIATED TARGET GENE ACTIVATION SYSTEM

NADK2 INHIBITION IN CANCER AND FIBROTIC DISORDERS

Methods and kits for identifying cancer treatment targets

EVOLUTION OF CYTIDINE DEAMINASES

Cleaning Compositions Comprising Enzymes

MULTICOMPONENT XNAZYME-BASED NUCLEIC ACID DETECTION SYSTEM

ENZYMES WITH RUVC DOMAINS

PROGRAMMABLE CAS9-RECOMBINASE FUSION PROTEINS AND USES THEREOF

BACTERIAL DELIVERY VEHICLE, PROCESS OF PRODUCTION AND USES THEREOF

CRISPR/RNA-GUIDED NUCLEASE-RELATED METHODS AND COMPOSITIONS FOR TREATING RHO-ASSOCIATED AUTOSOMAL-DOMINANT RETINITIS PIGMENTOSA (ADRP)

M6A-COUPLED EFFECTOR PROTEIN EXPRESSION SYSTEM AND METHODS OF MAKING AND USING SAME

ALL-IN-ONE DENDRIMER-BASED LIPID NANOPARTICLES ENABLE PRECISE HDR-MEDIATED GENE EDITING IN VIVO

COMPOSITIONS OF GLYCOPROTEIN PARTICLES

COMPOSITIONS AND METHODS FOR RAPID GENERATION OF MODIFIABLE STABLE CELL LINES

LIPID NANOPARTICLES COMPOSITIONS

GENE EXPRESSION REGULATORY SYSTEM USING CRISPR SYSTEM

FUSION PROTEINS COMPRISING AN INTEIN POLYPEPTIDE AND METHODS OF USE THEREOF

PACKAGING CELLS WITH TARGETED GENE KNOCKOUTS THAT IMPROVE RETROVIRAL VECTOR TITERS

Controllable Transcription

Application of Phosphorus Starvation Response Factor PHR2 in Plant and Arbuscular Mycorrhizal Symbiosis and Improving Phosphorus Nutrition

PHOTOCLEAVABLE GUIDE RNAS AND METHODS OF USE THEREOF

ENZYMES WITH RUVC DOMAINS

ENGINEERED MEGANUCLEASES THAT TARGET HUMAN MITOCHONDRIAL GENOMES

NUCLEASE WITH IMPROVED TARGETING ACTIVITY

EVOLUTION OF TALENS

TRANSCRIPTION ACTIVATOR-LIKE EFFECTORS FUSED TO INTEINS

LIMITED SELF-REPLICATING MRNA MOLECULAR SYSTEM, PRODUCING METHOD AND USE

EXPRESSION AND PURIFICATION OF CAS ENZYMES

COMPOSITIONS AND METHODS FOR IN VIVO NUCLEASE-MEDIATED GENE TARGETING FOR THE TREATMENT OF GENETIC DISORDERS

VARIANT-SPECIFIC EXOGENOUS DNA TEMPLATE-FREE CORRECTION OF PATHOGENIC VARIANTS

GENE EDITING OF DEEP INTRONIC MUTATIONS

EFFICIENT TRACELESS GENE EDITING SYSTEM FOR SALMONELLA AND USE THEREOF

METHODS AND COMPOSITIONS FOR GENETIC MODIFICATION AND THERAPEUTIC USE OF IMMUNE CELLS

DOUBLE KNOCKOUT (GT/CMAH-KO) PIGS, ORGANS AND TISSUES

MODIFIED BIOTIN-BINDING PROTEINS FOR IMMOBILIZATION

PROGRAMMABLE NUCLEASES AND METHODS OF USE

ENHANCED GUIDE NUCLEIC ACIDS AND METHODS OF USE

COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS TO ACCEPTOR CELLS

Virus-like Particles with Programmable Tropism and Methods of Use Thereof for Delivery to Cells

Adenoviral Vectors

METHODS FOR THE IDENTIFICATION OF VARIANT RECOGNITION SITES FOR RARE-CUTTING ENGINEERED DOUBLE-STRAND-BREAK-INDUCING AGENTS AND COMPOSITIONS AND USES THEREOF

COMPOUNDS AND METHODS FOR REDUCING PLN EXPRESSION

SMAD2 INHIBITION IN BETA CELLS FOR TYPE 2 DIABETES THERAPY

PROGRAMMABLE NUCLEASES AND METHODS OF USE

TYPE VI CRISPR ORTHOLOGS AND SYSTEMS

ENGINEERING OF DNASE ENZYMES FOR MANUFACTURING AND THERAPY

CAS10-BASED ASSAY FOR NUCLEIC ACID DETECTION

Minimal Virus-Like Particles and Methods of Use Thereof for Delivery of Biomolecules

MODIFIED CELLS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES

HIGH-THROUGHPUT METHODS FOR ANALYZING AND AFFINITY-MATURING AN ANTIGEN-BINDING MOLECULE

GENE THERAPY FOR TREATING BETA-HEMOGLOBINOPATHIES

PCSK9 ENDONUCLEASE VARIANTS, COMPOSITIONS, AND METHODS OF USE

EXOSOME GENE THERAPY FOR TREATING INNER EAR DISEASE

CHIMERIC ANTIGEN RECEPTORS TO TARGET CD5-POSITIVE CANCERS

HYPOIMMUNOGENIC CELLS HAVING TARGETED MODIFICATIONS IN MHC CLASS-I GENES AND METHODS OF USE

Minimal Human-Derived Virus-Like Particles and Methods of Use Thereof for Delivery of Biomolecules

NOVEL CRISPR ENZYMES AND SYSTEMS

Methods for genomic integration for host cells

RECOMBINANT VIRAL EXPRESSION VECTORS AND METHODS OF USE

CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION

COMPOSITIONS AND METHODS FOR SITE-SPECIFIC MODIFICATION

PE-STOP Gene Editing System and Gene Knockout Method and Application

MUTANT MAD7 PROTEIN

SYSTEMS AND METHODS FOR RECOVERING TARGET BIOMOLECULES FROM FIXED BED BIOREACTORS

Genome Editing by Directed Non-Homologous DNA Insertion Using a Retroviral Integrase-Cas Fusion Protein and Methods of Treatment

Compositions and Methods for Treatment of Myotonic Dystrophy Type 1 with CRISPR/SACAS9

Genetically Modified Cells Expressing Antigen-Containing Fusion Proteins and Uses Thereof

COMPOSITIONS, SYSTEMS, AND METHODS FOR GENERATING GENE-EDITED CELLS

EXTRACELLULAR VESICLES LOADED WITH AT LEAST TWO DIFFERENT NUCLEIC ACIDS

EFFECTOR PROTEINS AND METHODS OF USE

Engineered retrons and methods of use

RNA-Guided Transcriptional Regulation

PRIME EDITING-BASED SIMULTANEOUS GENOMIC DELETION AND INSERTION

CRISPR/CAS9 GENE EDITING SYSTEM AND APPLICATION THEREOF

VECTORS

CO-REGENERATION RECALCITRANT PLANTS

COMPOSITIONS AND METHODS FOR TREATING HYPERCHOLESTEROLEMIA

MATERIALS AND METHODS FOR TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY

BIALLELIC KNOCKOUT OF TRAC

GUIDE RNAS AND COMPOSITIONS FOR EDITING HUNTINGTIN GENE, AND METHODS RELATED THERETO

Gene editing system for editing the arylsulfatase A (ARSA) gene

Methods of Library Preparation

COMPACT PROMOTERS FOR GENE EDITING

MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF

COMPOSITIONS COMPRISING A VARIANT POLYPEPTIDE AND USES THEREOF

METHOD FOR SITE-SPECIFIC CONJUGATION OF NUCLEIC ACID TO CRISPR FAMILY PROTEIN, AND CONJUGATE THEREOF AND USE THEREOF

SYSTEM AND METHOD FOR GENOME EDITING BASED ON C2C1 NUCLEASES

GENE DELIVERY FOR PREVENTION AND TREATMENT OF BALDNESS

COMPOSITIONS AND METHODS FOR GENE EDITING FOR HEMOPHILIA A

PROGRAMMABLE NUCLEASES AND METHODS OF USE

Compositions and Methods for Treatment of Myotonic Dystrophy Type 1 with CRISPR/SluCas9

BASE EDITING FOR TREATING HUTCHINSON-GILFORD PROGERIA SYNDROME

COMPOSITIONS AND METHODS FOR FIBROBLAST GROWTH FACTOR RECEPTOR 3-MEDIATED DELIVERY TO ASTROCYTES

Compositions and Methods for the Treatment of Conditions Associated with Nucleotide Repeat Expansion

GENE CORRECTION FOR RAG2 DEFICIENCY IN HUMAN STEM CELLS

GENETICALLY ENGINEERED SWINE FOR PRECLINICAL VALIDATION

PRECISION-BASED IMMUNO-MOLECULAR AUGMENTATION (PBIMA) COMPUTERIZED SYSTEM, METHOD, AND THERAPEUTIC VACCINE

NANOPARTICLES-MEDIATED CRISPR-CAS9 FOR GENE THERAPY

COMPOSITIONS AND METHODS FOR GENOMIC EDITING BY INSERTION OF DONOR POLYNUCLEOTIDES

SYSTEMS AND METHODS FOR TARGETED INTEGRATION AND GENOME EDITING AND DETECTION THEREOF USING INTEGRATED PRIMING SITES

RNA-GUIDED NUCLEIC ACID MODIFYING ENZYMES AND METHODS OF USE THEREOF

INDUCIBLE MOSAICISM

COMPOSITIONS AND METHODS FOR RNA-ENCODED DNA-REPLACEMENT OF ALLELES

MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING

METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS)

Modified immune cells having enhanced function and methods for screening the same

COMPOSITIONS AND METHODS OF NUCLEIC ACID-TARGETING NUCLEIC ACIDS

ENHANCED DIVERSIFYING BASE EDITORS FOR DIRECTED EVOLUTION

CASZ COMPOSITIONS AND METHODS OF USE

NOVEL CRISPR ENZYMES, METHODS, SYSTEMS AND USES THEREOF

METHOD FOR PRODUCING HEMATOPOIETIC CELLS FROM STEM CELLS USING VASCULAR ORGANOIDS

METHOD FOR SEPARATING SPERMATOGONIAL STEM CELLS (SSCs) FROM FROZEN TESTICULAR TISSUE

NUCLEOTIDE EDITING TO REFRAME DMD TRANSCRIPTS BY BASE EDITING AND PRIME EDITING

LIPID NANOPARTICLE FORMULATIONS AND METHODS OF USE THEREOF

Sequence specific antimicrobials

COMPOSITIONS AND METHODS FOR MODULATING INNATE IMMUNE SIGNALING PATHWAYS

CYTOPLASMIC INCOMPATIBILITY FACTORS AND METHODS FOR CONTROLLING ANTHROPODS

COMPOSITIONS AND METHODS FOR RNA-ENCODED DNA-REPLACEMENT OF ALLELES

REPRESSOR PROTEINS FOR GENE REGULATION AND CRISPR INTERFERENCE

Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence

Polypeptide Variants

COMPOSITIONS AND METHODS FOR PRODUCING AND OPTIMIZING VIRAL VECTOR PRODUCER CELLS FOR CELL AND GENE THERAPY

NUCLEIC ACID PRODUCTS AND METHODS OF ADMINISTRATION THEREOF

MUTATION-INDEPENDENT GENE KNOCK-IN THERAPY TARGETING 5' UTR

DYSTROPHIN GENE EXON DELETION USING ENGINEERED NUCLEASES

METHODS TO GENETICALLY ENGINEER HEMATOPOIETIC STEM AND PROGENITOR CELLS FOR RED CELL SPECIFIC EXPRESSION OF THERAPEUTIC PROTEINS

GENETICALLY MODIFIED RAT MODELS FOR SEVERE COMBINED IMMUNODEFICIENCY (SCID)

CRISPR-MEDIATED CLEAVAGE OF OLIGONUCLEOTIDE-DETECTABLE MARKER CONJUGATES FOR DETECTION OF TARGET ANALYTES

GENE EDITING WITH A MODIFIED ENDONUCLEASE

TARGETED INSERTION VIA TRANSPORTATION

Modified Guide RNAs Comprising an Internal Linker for Gene Editing

METHODS OF ISOTHERMAL COMPLEMENTARY DNA AND LIBRARY PREPARATION

Engineered CRISPR-Cas9 nucleases with Altered PAM Specificity

MOBILE ENDONUCLEASES FOR HERITABLE MUTATIONS

HYPERACTIVE PIGGYBAC TRANSPOSASES

METHOD FOR GENE REPAIR IN PRIMARY HUMAN MUSCLE STEM CELLS (SATELLITE CELLS) IN VITRO AND GENETICALLY REPAIRED HUMAN MUSCLE STEM CELL

PERSONALIZED REDIRECTION AND REPROGRAMMING OF T CELLS FOR PRECISE TARGETING OF TUMORS

ASSEMBLED THREE-DIMENSIONAL CULTURES OF HUMAN NEURONS AND GLIA AND THEIR USE

COMPOSITIONS AND METHODS FOR DOMINANT ANTIVIRAL THERAPY

VECTOR SYSTEMS AND METHODS OF USING SAME

COMPOSITIONS AND METHODS FOR ASSESSING AND TREATING T CELL DYSFUNCTION

COMPOSITIONS AND METHODS FOR MODIFYING A PREDETERMINED TARGET NUCLEIC ACID SEQUENCE

Compositions and methods for organ specific delivery of nucleic acids

AMPLICON-FREE CRISPR-BASED ONE-POT DETECTION WITH LOOP-MEDIATED ISOTHERMAL AMPLIFICATION FOR POINT-OF-CARE DIAGNOSIS OF VIRAL PATHOGENS

MULTIPLEX RNA TARGETING

THERAPEUTIC GENOME EDITING IN WISKOTT-ALDRICH SYNDROME AND X-LINKED THROMBOCYTOPENIA

COMPOSITIONS COMPRISING A VARIANT POLYPEPTIDE AND USES THEREOF

COMPOSITIONS AND METHODS FOR HUMAN GENOMIC SAFE HARBOR SITE INTEGRATION

COMPOSITIONS AND METHODS FOR TREATING CEP290 ASSOCIATED DISEASE

TUNABLE TRANSPOSON SYSTEMS

Gene editing components, systems, and methods of use

DOMESTICATION OF A LEGUME PLANT

METHODS AND COMPOSITIONS FOR IN VIVO DIRECT GENOME EDITING IN PLANTS

SINGLE-VECTOR TYPE I VECTORS

GENOME EDITING FOR TREATING MUSCULAR DYSTROPHY

Driving Axon Regeneration by Activating STAT1 Signaling and cGAS-STING Pathway

SYSTEMS AND METHODS FOR GENOME-WIDE ANNOTATION OF GENE REGULATORY ELEMENTS LINKED TO CELL FITNESS

Regulation of transcription through CTCF loop anchors

COMPOSITIONS, METHODS, MODULES AND INSTRUMENTS FOR AUTOMATED NUCLEIC ACID-GUIDED NUCLEASE EDITING IN MAMMALIAN CELLS VIA VIRAL DELIVERY

GENERATION OF NOVEL CRISPR GENOME EDITING AGENTS USING COMBINATORIAL CHEMISTRY

TYPE V RNA PROGRAMMABLE ENDONUCLEASE SYSTEMS

COMPOSITIONS AND METHODS FOR GENERATING MALE STERILE PLANTS

METHODS FOR PRODUCING CAS3 PROTEINS

Applications of Engineered Streptococcus Canis Cas9 Variants on Single-Base PAM Targets

HSD17B13 VARIANTS AND USES THEREOF

TARGETED GENE INSERTION FOR IMPROVED IMMUNE CELLS THERAPY

COMPOUND AND METHOD FOR AN ALLELE-SPECIFIC EDITING OF THE ELANE GENE

Compositions and Methods for Genetically Modifying CIITA in a Cell

UNIVERSAL CAR-T CELL TARGETING GD2, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF

GENE SILENCING

METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION

MESENCHYMAL STEM CELL HAVING OXIDATIVE STRESS RESISTANCE, PREPARATION METHOD THEREFOR, AND USE THEREOF

METHODS AND COMPOSITIONS FOR SEQUENCING LIBRARY NORMALIZATION

ENGINEERED TARGET SPECIFIC NUCLEASES

NUCLEASE-GUIDED NON-LTR RETROTRANSPOSONS AND USES THEREOF

HOMOLOGOUS RECOMBINATION VIA TRANSCRIPTIONAL ACTIVATION

MODIFIED ORTHOPOXVIRUS VECTORS

T-DNA Free Gene Editing through Transient Suppressing POLQ in Plants

CHLOROPLAST CYTOSINE BASE EDITORS AND MITOCHONDRIA CYTOSINE BASE EDITORS IN PLANTS

SEMI-RATIONAL GENOME EVOLUTION ENGINEERING METHOD FOR PLANTS

PROTEIN ARGININE METHYLTRANSFERASE 9 INHIBITORS AND METHODS OF USE

COMPOSITIONS FOR GENOME EDITING

RNA-TRIGGERED PROTEIN CLEAVAGE AND APPLICATIONS BY THE CRISPR CAS7-11-CSX29 COMPLEX

Allosteric Conditional Guide RNAs for Cell-Selective Regulation of CRISPR/Cas

DIFFERENTIAL KNOCKOUT OF AN ALLELE OF A HETEROZYGOUS BESTROPHIN 1 GENE

TRANSCRIPTIONAL PROGRAMMING IN A BACTEROIDES CONSORTIUM

NEEDLE-BASED DEVICES AND METHODS FOR IN VIVO DIAGNOSTICS OF DISEASE CONDITIONS

GENOME EDITING SYSTEMS COMPRISING REPAIR-MODULATING ENZYME MOLECULES AND METHODS OF THEIR USE

SITE-SPECIFIC GENOME MODIFICATION TECHNOLOGY

CAPTURE OF NUCLEIC ACIDS USING A NUCLEIC ACID-GUIDED NUCLEASE-BASED SYSTEM

COMPOSITIONS AND METHODS FOR THE SELF-INACTIVATION OF BASE EDITORS

ADENOSINE DEAMINASE BASE EDITORS AND METHODS OF USING SAME TO MODIFY A NUCLEOBASE IN A TARGET SEQUENCE

DNASE 1-LIKE 2 ENGINEERED FOR MANUFACTURING AND USE IN THERAPY

RATIONALLY-DESIGNED MEGANUCLEASES WITH ALTERED SEQUENCE SPECIFICITY AND DNA-BINDING AFFINITY

Methods and compositions for in vivo gene editing based cell-type-specific cellular engineering

COMPOSITIONS AND METHODS FOR EPIGENETIC REGULATION OF HBV GENE EXPRESSION

METHODS FOR EXPANDING REGULATORY T CELLS

TARGETED DNA DEMETHYLATION AND METHYLATION

Methods and products for genetic engineering

METHODS AND COMPOSITIONS FOR REDUCING NUCLEIC ACID VECTOR-INDUCED TOXICITY IN THE INNER EAR

MODULATION OF GENE EXPRESSION FOR DISEASE TREATMENT

SITE-SPECIFIC CLEAVAGE AND ELIMINATION OF DNA IN BACTERIAL SPECIES WITH SEGMENTED CHROMOSOMES

NOVEL OMNI-50 CRISPR NUCLEASE

ZIP-IN TECHNOLOGY FOR ANTIVIRAL THERAPEUTIC NANOFORMULATIONS

COMPOSITIONS AND METHODS FOR SELECTIVE ELIMINATION AND REPLACEMENT OF HEMATOPOIETIC STEM CELLS

SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING

CD94 ENGINEERED CELL AND COMPOSITION THEREOF

COMPOSITIONS AND METHODS FOR REMOVING DENTAL CALCULI

RECOMBINANT GENOME, AND NON-HUMAN MAMMALIAN CELL AND PRODUCTION METHOD THEREFOR AND USE THEREOF

BIRDS FOR PRODUCING FEMALE HATCHLING AND METHODS OF PRODUCING SAME

CLICKABLE AND CLEAVABLE SENSING SURFACE AND METHOD OF MAKING THE SAME

COMPOSITIONS AND METHODS FOR TEMPORAL CONTROL OF CELL MODULATION

Detection of nucleic acid and non-nucleic acid target molecules

COMPOSITIONS AND METHODS FOR NUCLEIC ACID DETECTION BY LATERAL FLOW ASSAYS

Protein-Based Signal Amplification

METHOD FOR PRODUCING DNA-EDITED EUKARYOTIC CELL, AND KIT USED IN THE SAME

Compositions and Methods Comprising a TTR Guide RNA and a Polynucleotide Encoding an RNA-Guided DNA Binding Agent

NUCLEASE-MEDIATED GENOME EDITING OF PRIMARY CELLS AND RELATED KITS

CRISPR/CAS9-MEDIATED MEANS AND METHODS FOR CELL REPROGRAMMING

COMPOSITIONS FOR AND METHODS OF ENGINEERING THE TRANSCRIPTOME

METHODS AND COMPOSITIONS FOR COMBINATORIAL TARGETING OF THE CELL TRANSCRIPTOME

COMPOSITIONS AND METHODS FOR IMPROVED GENE EDITING

Curing disease by transcription regulatory gene editing

USES OF ADENOSINE BASE EDITORS

CRISPR enzymes and systems

GENETICALLY MODIFIED CELLS AND USES THEREOF FOR PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE

CHEMERIN INHIBITORS AND USES THEREOF FOR TREATING KIDNEY CANCER

COMPOSITIONS AND METHODS FOR THE TARGETING OF PCSK9

BASE EDITING OF TRANSTHYRETIN GENE

COMPOSITIONS AND METHODS FOR THE TARGETING OF PCSK9

USE OF A SPLIT dCAS FUSION PROTEIN SYSTEM FOR EPIGENETIC EDITING

PREPARATION METHOD AND APPLICATION OF CTL CELL

METHODS AND COMPOSITIONS FOR PRODUCTION OF GENETICALLY MODIFIED PRIMARY CELLS

COMPOUND AND METHOD FOR THE PROPHYLAXIS AND TREATMENT OF LEUKEMIA

Pathogen-resistant animals having modified CD163 genes

METHOD FOR CONVERTING NUCLEIC ACID SEQUENCE OF CELL SPECIFICALLY CONVERTING NUCLEIC ACID BASE OF TARGETED DNA USING CELL ENDOGENOUS DNA MODIFYING ENZYME, AND MOLECULAR COMPLEX USED THEREIN

SELECTION BY ESSENTIAL-GENE KNOCK-IN

METHOD FOR PRODUCING DNA-EDITED EUKARYOTIC CELL, AND KIT USED IN THE SAME

CRISPR/CAS9 COMPLEX FOR GENOMIC EDITING

GENETICALLY MODIFIED SORGHUM AND METHODS OF GENETICALLY ENGINEERING SORGHUM TO CONTROL CROSS-INCOMPATIBILITY

INCREASING GENE EDITING AND SITE-DIRECTED INTEGRATION EVENTS UTILIZING DEVELOPMENTAL PROMOTERS

MULTIPLEX GENOME EDITING METHOD AND SYSTEM

CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION

SYNTHETIC IMMUNOMODULATION WITH A CRISPR SUPER-REPRESSOR IN VIVO

PRODUCTION OF UNNATURAL NUCLEOTIDES USING A CRISPR/CAS9 SYSTEM

Targeted non-viral DNA insertions

RECOMBINANT CONSTRUCT FOR CANCER TREATMENT

REGULATION OF METABOLISM AND OBESITY BY MITOCHONDRIAL MUL1 E3 UBIQUITIN LIGASE

EXPRESSION OF FOXP3 IN EDITED CD34+ CELLS

COMPOSITIONS AND METHODS FOR TREATING TRANSTHYRETIN AMYLOIDOSIS

FUSION PROTEINS FOR BASE EDITING

ENZYMES WITH RUVC DOMAINS

METHODS AND COMPOSITIONS FOR GENERATING STEM CELL-DERIVED IMMUNE CELLS WITH ENHANCED FUNCTION

SYNTHETIC CAS12A FOR ENHANCED MULTIPLEX GENE CONTROL AND EDITING

ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF

Dimerization screening assays